Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
StandardStandard
Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis. / Hughes, D.; Hughes, D.A.; Al-Zubiedi, S. et al.
2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..
2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..
Allbwn ymchwil: Cyfraniad at gynhadledd › Papur
HarvardHarvard
Hughes, D, Hughes, DA, Al-Zubiedi, S, Hanson, A, Jorgensen, A & Pirmohamed, M 2009, 'Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.', Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009., 3/01/02.
APA
Hughes, D., Hughes, D. A., Al-Zubiedi, S., Hanson, A., Jorgensen, A., & Pirmohamed, M. (2009). Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..
CBE
Hughes D, Hughes DA, Al-Zubiedi S, Hanson A, Jorgensen A, Pirmohamed M. 2009. Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..
MLA
Hughes, D. et al. Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.. 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009., 03 Ion 0002, Papur, 2009.
VancouverVancouver
Hughes D, Hughes DA, Al-Zubiedi S, Hanson A, Jorgensen A, Pirmohamed M. Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.. 2009. Papur a gyflwynwyd yn 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009..
Author
RIS
TY - CONF
T1 - Impact of pharmacogenetics on the costs of managing adverse events with warfarin: A prospective analysis.
AU - Hughes, D.
AU - Hughes, D.A.
AU - Al-Zubiedi, S.
AU - Hanson, A.
AU - Jorgensen, A.
AU - Pirmohamed, M.
PY - 2009/1/1
Y1 - 2009/1/1
M3 - Paper
T2 - 14th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research, Orlando, May 2009.
Y2 - 3 January 0002
ER -